Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996. His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 60 countries and has published 482 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.
Sandro C. Esteves, MD., PhD. is a reproductive urologist who specializes in treating male infertility, particularly its connection with assisted reproductive technology (ART). He is the founder and medical director of ANDROFERT, a fertility center based in Campinas, Brazil, dedicated to male reproductive health. He is also a Collaborating Professor of Urology at the University of Campinas (UNICAMP), Brazil, and an Honorary Professor of Reproductive Medicine at Aarhus University, Denmark.
Dr. Esteves earned his medical degree in 1990 from the Faculty of Medical Sciences at UNICAMP, where he also completed his urology residency. He pursued a research fellowship at the Cleveland Clinic Foundation in the United States, focusing on male infertility. He later obtained a master’s degree in Surgery from UNICAMP and a PhD in Urology from the Federal University of São Paulo (EPM–UNIFESP). With more than 25 years of experience, Dr. Esteves has significantly advanced our understanding of male infertility in both clinical and academic settings. His work has focused on sperm DNA fragmentation, the importance of accurate semen analysis, and the limitations of basic diagnostics. He has underscored the role of varicocele repair and hormonal therapy in improving male fertility, particularly in non-obstructive azoospermia. He is the lead author of the APHRODITE criteria, a novel classification system designed to guide the treatment of men with testicular dysfunction and improve fertility outcomes through personalized hormonal therapy.
Dr. Esteves is a prolific author with over 350 published scientific papers, as well as numerous book chapters, and textbooks. He holds a Hirsch index of 78 and has been cited over 20,ooo times. According to the Science-Wide Author Databases of Standard Citation Indicators (Elsevier/Stanford), he is ranked among the top 1% of global researchers. He is a founding member of the POSEIDON group, which developed new stratification criteria for couples with a low prognosis undergoing ART. In addition to his clinical work and research, Dr. Esteves serves as Associate Editor/Section Editor for several journals, including Human Reproduction, Andrology, Reproductive Biomedicine Online, Frontiers in Endocrinology, and the International Brazilian Journal of Urology. He is also an editorial board member of many journals, including Nature Reviews Urology and International Urology and Nephrology. At ANDROFERT, Dr. Esteves has led initiatives to implement cleanroom technologies and quality management systems (ISO 9001), achieving national recognition for excellence in male fertility care. His team has consistently delivered outstanding results in treating complex cases of male infertility. A frequent speaker at national and international conferences, Dr. Esteves has received numerous research grants and awards. He serves as the head of the Andrology Committee at the Brazilian Society of Human Reproduction and is the Topic Leader of the Male Infertility Group for the WHO Infertility Guidelines.
Professor Peter Humaidan is a specialist in reproductive endocrinology, professor at The Fertility Clinic Skive Regional Hospital, Aarhus University, Denmark and Honorary professor at Odense University, Denmark. During his scientific work he has primarily focused on developing individualized treatment protocols for the infertile patient. His doctoral thesis (DMSc) explored the role of LH during the follicular and luteal phases in controlled ovarian stimulation. His main fields of interest are triggering of ovulation with GnRH agonist, role of LH during the follicular and luteal phases, role of the female genital tract microbiota for reproductive outcomes, OHSS prevention, and role of sperm DNA fragmentation for spontaneous and assisted reproduction. He is the founder of the international society “The Copenhagen GnRHa Triggering Workshop Group” who introduced the GnRHa trigger in modern IVF, changing trigger policies worldwide. He is co-founder of the POSEIDON group which suggested a new stratification of the poor responder patient, and a past board member of the ESHRE SIG Endocrinology Group. Finally, he is also co-founder of the APHRODITE group which suggested a new classification of the infertile male into five sub-groups who might benefit from medical treatment in terms of spermatogenesis. He is in the Elsevier, Stanford global list of 2% top scientists, and he authored and co-authored 270 + articles (H-index 70, Google Scholar) in international peer reviewed journals as well as chapters in textbooks and the Danish guidelines for OHSS prevention. Peter Humaidan has a wide international scientific network and is frequently invited as a speaker at international conferences.
Dr. Vipin Chandra is an esteemed gynaecologist with a distinguished background in reproductive and foetal medicine. With an MBBS, DGO, and a fellowship in Foetal Medicine and Reproductive Medicine, he has demonstrated exceptional proficiency in managing complex cases, having performed over 1000 foetal invasive procedures and more than 1000 assisted reproductive technology (ART) cycles.
Currently serving as the Chief of Clinical and Lab Operations at Indira IVF. Dr.Chandra oversees clinical and embryology operations across all 125 Indira Infertility and Hospital Pvt. Ltd. (IIHPL) centres, ensuring the highest standards of patient care.
Dr. Chandra’s special interests include male infertility, recurrent implantation failure, foetal echocardiography, neurosensorial, and fatal intervention. His active involvement in professional organizations such as ESHRE, SFM, ISAR, and FOGSI ensures he remains at the forefront of the latest developments and best practices in reproductive medicine. Dr. Chandra’s significant contributions to medical literature include multiple publications in prestigious international journals and a chapter on “Ultrasound in the First Trimester” in the book “A Practical Guide to Gynaecology.” His achievements were recognized with the National Youth Icon award at the National Fertility Awards in 2023.
Professor Hugues was the head of Reproductive Medicine Unit at University Paris XIII.
He trained in Endocrinology and Gynaecology before being appointed as Professor of Reproductive Medicine and Development.
He succeeded in PhD in Biology of Reproduction at the University Paris XI
He was a member of many international scientific societies (ESHRE – ASRM – SGI)
His interest for the control of ovarian function and ovulation induction led him to conduct several clinical trials and to publish more than hundred articles in peer reviews.
Matheus Roque is the Scientific Director at Origen – Center for Reproductive Medicine, Brazil. Dr. Roque obtained his degree in Medicine in 2003 at the Marilia Medical School, Mar lia, Brazil and he is currently working towards his PhD in Women’s Health at the Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. He obtained his Masters in Reproductive Medicine in 2012 at the Universitat Aut noma de Barcelona, Barcelona, Spain, and completed a Fellowship in Human Reproduction during 2009 –2010 at the Universidade Federal de S o Paulo, S o Paulo, Brazil. Dr. Roque has authored many scientific articles and book chapters, and has served as a reviewer for several indexed medical journals. He has been an active participant in many international and national congresses in reproductive medicine and urology, presenting abstracts and lectures. Dr. Roque has participated in the 2015 European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting as an Invited Speaker delivering the lecture Towards a “freeze-all” policy. Fertility and Sterility has recently acknowledged Dr. Roque in recognition of his contribution to the quality of the journal. Moreover, one of his papers featured in the top 5 most highly cited papers published in Fertility and Sterility during 2014 and 2015. He has been recently awarded with the GFI – Grant for Fertility Innovation, with the project entitled “Pharmacogenetic algorithm for individualized Controlled Ovarian Stimulation (iCOS)”. He is currently a member of ESHRE, the American Society for Reproductive Medicine, the Brazilian Society for Assisted Reproduction, and the Brazilian Society of Urology.
Dr. Shashank Sanagoudar is a reproductive medicine specialist with extensive clinical, academic, and research expertise. He serves as the Head of Clinical Research and Academics at the Indira Fertility Academy, Consultant in Reproductive Medicine at Indira IVF, and the National Lead for the FNB – Fellowship in Reproductive Medicine program, where he oversees advanced training across all centres.
Dr. Shashank completed his Bachelors in Medicine (2015) and Masters in Obstetrics & Gynecology (2021), followed by a Fellowship in Reproductive Medicine and Laparoscopy (2022). In his leadership roles, he mentors team of gynecologists, driving protocol development, clinical quality assurance, and outcome optimization.
A committed academician, he has trained 100+ gynecologists nationally and internationally and is invited as a speaker at International and National scientific conferences. He is an active member of ESHRE, SFM, ISAR, and FOGSI, contributing to global and national reproductive science communities.
Dr. Shashank holds key institutional leadership roles, including positions on the Scientific Review Committee, Scientific Advisory Board, Institutional Ethics Committee, and the Medical Advisory Board. He is recognized for his expertise in designing and standardizing clinical SOPs, ensuring consistent, protocol-driven, high-quality patient care.
Alberto Vaiarelli is a Surgeon, specialist in Obstetrics and Gynaecology, PhD in Experimental Endocrinological and Metabolic Sciences with a Master’s Degree in Andrology and Reproductive Medicine and National Scientific Qualification for First Level University Professor. For more than 15 years he has been dealing with couple sterility and PMA techniques.
Medical and Scientific Coordinator of the Genera Roma center.
National Secretary of the Italian Society of Fertility-Sterility and Reproductive Medicine
Teacher in the disciplinary field of Gynecology and Reproductive Medicine in various Level I-II University Masters and Specialty courses in the Medical area.
Member of the teaching staff for second level Master’s degrees at the University of Pavia.
Stay in the know with our CME updates
